Recent advances in the diagnosis of intestinal tuberculosis.
Diagnosis
GenExpert
IGRA
Immunological marker
Intestinal tuberculosis
Multiplex-PCR
PCR
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
received:
31
03
2021
accepted:
29
11
2021
entrez:
1
3
2022
pubmed:
2
3
2022
medline:
3
3
2022
Statut:
epublish
Résumé
Intestinal tuberculosis still has a high incidence, especially in developing countries. The biggest challenge of this disease is the establishment of the diagnosis because the clinical features are not typical. Investigations such as culture, acid-fast bacilli (AFB) staining, and histopathology have low sensitivity, so other investigations are needed. Latest molecular-based diagnostic modalities such as GeneXpert, interferon-gamma (IFN-γ) release assays (IGRA), polymerase chain reaction (PCR), multiplex-PCR, and immunological markers are expected to help diagnose intestinal tuberculosis. This article review will examine the latest diagnostic modalities that can be used as a tool in establishing the diagnosis of intestinal tuberculosis. Through a literature search, we were able to review the diagnostic values of various available diagnostic modalities as the appropriate additional test in intestinal tuberculosis. Culture as a gold standard has a sensitivity and specificity value of 9.3% and 100% with the MGIT BACTEC system as the most recommended medium. The sensitivity values of AFB staining, histopathology examination, GeneXpert, IGRA, PCR, multiplex-PCR and, immunological markers were ranged between 17.3 and 31%; 68%; 81-95.7%; 74-88%; 21.6-65%; 75.7-93.1%; and 52-87%, respectively. Meanwhile the specificity values were 100%; 77.1%; 91-100%; 74-87%; 93-100%; 96.4-100%; and 70-95%, respectively. The combination of clinical examination, conventional examination, and the latest molecular-based examination is the best choice for establishing the diagnosis of intestinal tuberculosis. Most recent modalities such as multiplex PCR and immunological marker examinations are diagnostic tools that deserve to be used in diagnosing intestinal tuberculosis as their sensitivity and specificity values are quite high and more evidences are expected to support the application of these examinations shortly soon.
Sections du résumé
BACKGROUND
BACKGROUND
Intestinal tuberculosis still has a high incidence, especially in developing countries. The biggest challenge of this disease is the establishment of the diagnosis because the clinical features are not typical. Investigations such as culture, acid-fast bacilli (AFB) staining, and histopathology have low sensitivity, so other investigations are needed. Latest molecular-based diagnostic modalities such as GeneXpert, interferon-gamma (IFN-γ) release assays (IGRA), polymerase chain reaction (PCR), multiplex-PCR, and immunological markers are expected to help diagnose intestinal tuberculosis. This article review will examine the latest diagnostic modalities that can be used as a tool in establishing the diagnosis of intestinal tuberculosis.
RESULTS
RESULTS
Through a literature search, we were able to review the diagnostic values of various available diagnostic modalities as the appropriate additional test in intestinal tuberculosis. Culture as a gold standard has a sensitivity and specificity value of 9.3% and 100% with the MGIT BACTEC system as the most recommended medium. The sensitivity values of AFB staining, histopathology examination, GeneXpert, IGRA, PCR, multiplex-PCR and, immunological markers were ranged between 17.3 and 31%; 68%; 81-95.7%; 74-88%; 21.6-65%; 75.7-93.1%; and 52-87%, respectively. Meanwhile the specificity values were 100%; 77.1%; 91-100%; 74-87%; 93-100%; 96.4-100%; and 70-95%, respectively.
CONCLUSION
CONCLUSIONS
The combination of clinical examination, conventional examination, and the latest molecular-based examination is the best choice for establishing the diagnosis of intestinal tuberculosis. Most recent modalities such as multiplex PCR and immunological marker examinations are diagnostic tools that deserve to be used in diagnosing intestinal tuberculosis as their sensitivity and specificity values are quite high and more evidences are expected to support the application of these examinations shortly soon.
Identifiants
pubmed: 35227196
doi: 10.1186/s12876-022-02171-7
pii: 10.1186/s12876-022-02171-7
pmc: PMC8885312
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
89Subventions
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Organisme : Universitas Indonesia
ID : PUTI Grant NKB-5/UN2.RST/HKP.05.00/0020
Informations de copyright
© 2022. The Author(s).
Références
BMC Infect Dis. 2020 Mar 30;20(1):255
pubmed: 32228479
Gastroenterol Rep (Oxf). 2016 Feb;4(1):59-67
pubmed: 25969456
Intest Res. 2021 Apr;19(2):232-238
pubmed: 32375209
J Immunol Res. 2015;2015:985302
pubmed: 25969837
JGH Open. 2018 Oct 17;3(1):32-37
pubmed: 30834338
World J Emerg Surg. 2019 Jul 12;14:33
pubmed: 31338118
J Glob Infect Dis. 2013 Apr;5(2):49-53
pubmed: 23853431
Radiographics. 2007 Sep-Oct;27(5):1255-73
pubmed: 17848689
Inflamm Intest Dis. 2019 Apr;3(4):155-160
pubmed: 31111030
J Assoc Physicians India. 2016 Feb;64(2):38-47
pubmed: 27730779
J Med Imaging Radiat Oncol. 2019 Jun;63(3):329-339
pubmed: 30932343
Dig Dis Sci. 2013 Aug;58(8):2301-7
pubmed: 23625284
Trop Med Int Health. 2019 Jan;24(1):81-90
pubmed: 30338607
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28084201
PLoS One. 2018 Feb 28;13(2):e0193433
pubmed: 29489879
Diagn Microbiol Infect Dis. 2013 May;76(1):51-5
pubmed: 23608350
Abdom Imaging. 2015 Jun;40(5):1104-9
pubmed: 25416003
Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1217-1221
pubmed: 30295112
Am J Gastroenterol. 2017 Mar;112(3):415-427
pubmed: 28045023
Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):493-500
pubmed: 31758440
Therap Adv Gastroenterol. 2020 May 18;13:1756284820922003
pubmed: 32523624
J Clin Gastroenterol. 2016 Jul;50(6):470-5
pubmed: 26974755
PLoS One. 2016 Feb 19;11(2):e0149258
pubmed: 26894283
Saudi J Gastroenterol. 2017 Jan-Feb;23(1):3-10
pubmed: 28139494
World J Gastroenterol. 2019 Jan 28;25(4):418-432
pubmed: 30700939
J Gastroenterol Hepatol. 2014 Sep;29(9):1664-70
pubmed: 24910240
Sci Transl Med. 2013 Jan 30;5(170):170ra13
pubmed: 23363977
Ther Adv Infect Dis. 2019 Aug 07;6:2049936119863939
pubmed: 31431826
Chin Med J (Engl). 2016 Jun 5;129(11):1330-3
pubmed: 27231171
Clin Exp Gastroenterol. 2018 Mar 13;11:97-103
pubmed: 29559804
mBio. 2017 Aug 29;8(4):
pubmed: 28851844
World J Gastroenterol. 2010 May 28;16(20):2496-503
pubmed: 20503449
World J Gastroenterol. 2013 Nov 28;19(44):8133-40
pubmed: 24307809
Thorax. 2010 Mar;65(3):271-6
pubmed: 20335301
PLoS One. 2020 Nov 30;15(11):e0242879
pubmed: 33253239